Remove Download Remove Epilepsy Remove Safety Remove Treatment
article thumbnail

How to Participate in Medical Marijuana Research

CannaMD

By joining, you will contribute to research that will help the consortium learn more about medical marijuana and improve the usefulness and safety for people who are using or considering using medical marijuana, just like yourself. Download our FREE Medical Marijuana: Basics e-book! Coronavirus. Crohn’s disease. Depression.

Marijuana 119
article thumbnail

Use of Cannabis-based medicinal products: NICE guidelines

Cannabis Law Report

Severe treatment-resistant epilepsy. Consider nabilone as an add-on treatment for adults (18 years and over) with chemotherapy-induced nausea and vomiting which persists with optimised conventional antiemetics. 1.4 Severe treatment-resistant epilepsy. Recommendations for research. Rationale and impact.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CBD Market Report

Project CBD

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Available at: www.fda.gov/media/131878/download. 2021.108514.

CBD 144
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

article thumbnail

Medical Cannabis Company Sunshine Coast Tikun Oceana, formerly known as Medifarm Calls In The Administrators

Cannabis Law Report

The schedule eight pharmaceutical medicine has gained federal approval to treat conditions including cancer-related pain, nausea and vomiting, multiple sclerosis and epilepsy, and for use in palliative care. But bottlenecks remain to doctors prescribing the controversial treatment. “Everything will be quality tested onsite.